TG Therapeutics | TGTX - 股本和储备



金融业
股票价格
USD
资产
USD 1.06B
现金及等价物
USD 199.51M
销售成本
USD 38.14M
流动资产
USD 630.76M
流动负债
USD 153.76M
债务
USD 245.34M
EBIT
USD 50.49M
EBITDA
USD 32.69M
员工
338
EPS每股收益
USD 0.14
股本和储备
USD 648.02M
销售毛利
USD 154.43M
债务利息支出
USD 6.53M
贷款资金
USD 245.65M
市值
USD 5.34B
净收入
USD 23.04M
营业费用
USD 142.08M
营业利润
USD 50.49M
普通股股本
USD 155.21M
PE价格收益
10.76
税前利润
USD 45.09M
销售收入
USD 192.57M
销售和管理费用
USD 50.73M
股票
USD 125.59M
贸易债权人
USD 61.64M
应收帐款人
USD 265.38M


股本和储备 更改 日
AbbVie USD -3.27B 628M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Amgen USD 8.66B 961M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Curis USD 5.46M 19.45M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
J&J USD 81.54B 3.07B 2025-12
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novavax USD -127.75M 28.92M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Verastem USD 57.2M 72.72M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12